Marker Therapeutics (MRKR) Misses Q3 EPS by 12c

Marker Therapeutics (NASDAQ: MRKR) reported Q3 EPS of ($0.12). Revenue for the quarter came in at $1.23 million.

For earnings history and earnings-related data on Marker Therapeutics (MRKR) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Ishares Msci South Korea Capped Etf (EWY) spreader of 10K contracts January 170 and 190 puts into Korean market lower
• Carnival Corp. (CCL) call put ratio 1.2 calls to 1 put into quarter results